Provention bio reports third quarter 2021 financial results and provides business update

Red bank, n.j., nov. 4, 2021 /prnewswire/ -- provention bio, inc. (nasdaq: prvb), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, today reported financial results for the third quarter ended september 30, 2021 and provided a business update.
PRVB Ratings Summary
PRVB Quant Ranking